QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective 期刊论文 TUMORI JOURNAL, 2021 作者:  Tong, Ying-hui;  Ding, Hai-ying;  Xin, Wen-xiu;  Zhong, Li-ke;  Xu, Gao-qi 收藏  |  浏览/下载：38/0  |  提交时间：2021/08/30 Cost-effectiveness  durvalumab  etoposide plus platinum chemotherapy  first-line treatment  SCLC   Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix 期刊论文 GYNECOLOGIC ONCOLOGY, 2017, 卷号: 147, 期号: 3 作者:  Pei, Xuan;  Xiang, Libing;  Ye, Shuang;  He, Tiancong;  Cheng, Yufan 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Small cell neuroendocrine carcinoma of the cervix  Radical surgery  Adjuvant therapy  EP chemotherapy  Disease recurrence   Clinical Effect Observation of Compound Kushen Injection Combined with EP Regimen Chemotherapy for Small Cell Lung Cancer (SCLC) 会议论文 作者:  Yun, Feng S.;  Yao, Zhang;  Yuan, Li C. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Compound Kushen Injection  chemotherapy  SCLC  EP